Indications for percutaneous endoscopic gastrostomy and survival in old adults

Figures & data

Table 1. Number of patients, age (±SD), and indications for PEG in the various diagnosis groups

	All patients	Stroke	Dementia	Mb Parkinson	Other neurology. disorders	Malignant esophageal obstruction	Other malignancies	Miscellaneous	No data available
N (%)	201	97 49	16 (8)	12 (6)	13 (6)	33^a (16)	5 (2)	23 (12)	2 (1)
Age, years	79±7	81±6	80.5±7	73±5	75±8	74±6	74±4	78±8
Females, n (%)	94 (47)	52 (54)	9 (56)	4 (33)	8 (62)	8 (24)	2 (40)	10 (43)
Indication for PEG (n,%)
Dysfagia	173 (86)	92 (95)	7 (44)	11 (92)	13 (100)	32 (97)	2 (40)	16 (70)
Inability to eat	12 (6)	5 (5)	2 (12.5)	1 (8)	0	0	1 (20)	3 (13)
Nutritional support	8 (4)	0	2 (12.5)	0	0	1 (3)	1 (20)	4 (17)
No data available	8 (4)	0	5 (31)	0	0	0	1 (20)	0	2

^aCancer of esophagus (20), lung (3), pharynx (2), larynx (2), tonsils (2), mouth (2), thyroid (1), and vocal cords (1).

Figure 1.  Survival time, all patients, n=191.

Table 2. Median survival in days and 1-,3-, 6-, and 12-month mortality for various diagnostic groups, n=191

		Mortality (%)
Median survival in days (95% CI)		Days
		30	90	180	365
Dementia (n=16)	244 (49–439)	25	37	37	58
Mb Parkinson (n=11)	233 (0–660)	9	18	36	55
Miscellaneous (n=19)	130 (45–215)	17	39	61	61
Stroke (n=95)	119 (15–223)	22	46	55	67
Malignant obstruction (n=31)	106 (63–149)	23	42	68	77
Other neurological diseases (n=13)	75 (15–135)	23	54	62	77
Other malignancy (n=4)	—	—	—	—	—
No data available (n=2)	—	—	—	—	—
All patients (n=191)	123 (74–172)	22	42	56	67